Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0480+0.0020 (+4.35%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
1,602
1,602
747.181
840.815
1,289
Selling general and administrative
891.44
891.44
1,376
1,620
1,991
Total operating expenses
3,285
3,285
3,022
3,113
4,206
Operating income or loss
-3,285
-3,285
-3,022
-3,113
-4,206
Interest expense
2.37
2.37
3.32
0.3
-
Total other income/expenses net
1,246
1,246
487.235
1,108
789.211
Income before tax
-2,023
-2,023
-2,532
-1,996
-3,365
Income tax expense
0
0
0
0
0
Income from continuing operations
-2,023
-2,023
-2,532
-1,996
-3,365
Net income
-2,023
-2,023
-2,532
-1,996
-3,365
Net income available to common shareholders
-2,023
-2,023
-2,532
-1,996
-3,365
Basic EPS
-0.02
-
-0.03
-0.03
-0.06
Diluted EPS
-0.02
-
-0.03
-0.03
-0.06
Basic average shares
104,303
-
78,218
68,953
54,616
Diluted average shares
104,303
-
78,218
68,953
54,616